What You Need to Know About Bipolar Depression
You must understand that bipolar disorder is a kind of condition which affects all types of individuals. Children and adults are affected by this condition. Such is a fact that you must understand. The women are going to suffer the most from such type of depression which is called bipolar depression disorder.
This isn’t very strange or far-fetched in any case, since even when the women would suffer from such regular bipolar kind of depression or the depressive disorder, they would often spend more time depressed than they do being manic. This isn’t to say that only the women are depressive, the men also are and they may get affected by such condition.
The bipolar kind of disorder is also known as manic depression since such is a mental condition wherein you interchange often between such phases of depression and mania. If you suffer from such bipolar depression, you won’t have to spend a lot of time being manic as you spend getting depressed.
Such kind of depression is a form of disorder and you must understand that it is easy to mistakenly diagnose as bipolar disorder because of the sameness of these symptoms. Because of this, the doctor must have to keep you around for a long time when they would try to diagnose the condition that you have. It certainly won’t be flattering to either of you when you are treated for a wrong thing.
The bipolar affective disorder is another name for such bipolar disorder or the manic-depressive illness. But, you don’t like to mistake this for bipolar depression disorder. This is closely related with the symptoms of the depressive phase of the bipolar disorder but just a few of the mania.
The monotherapy trials from placebo is actually the gold-standard design in knowing the efficacy when it comes to the treatment of bipolar depression. If the efficacy would get proven as monotherapy, those new compounds can be tested in the adjunctive-medication placebo-controlled trials. Those younger adults, without the established need for such long-term medication can be suitable for the clinical trials needing placebo-controls. Such switch to mania or the hypomania can perhaps be the result of the active treatment for such bipolar depression.
Some of the medications like the tricyclic antidepressants as well as venlafaxine can be more likely to prove switch than the others but the increased rate of the switch cannot be seen until around ten weeks of treatment. Hence, the 12-week trials against placebo are required to determine such risk of switch and to establish such continuing effects. You have to know that such careful assessment at six to eight weeks are needed to guarantee that the patients who fail to respond won’t continue in the study for such unacceptable periods of time.